← Browse by Condition
Medical Condition
colorectal neoplasms
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 1, Phase 2, Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for colorectal neoplasms sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — colorectal neoplasms Clinical Trials
How many clinical trials are currently recruiting for colorectal neoplasms?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for colorectal neoplasms, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for colorectal neoplasms?
colorectal neoplasms research spans Phase 1 (3 trials), Phase 2 (2 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a colorectal neoplasms clinical trial?
Eligibility criteria for colorectal neoplasms trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 3
Phase 2 2
Phase 4 1
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06447662 Phase 1
Recruiting
Enrollment
330 pts
Location
United States, China...
Sponsor
Pfizer
NCT05286814 Phase 2
Recruiting
Enrollment
70 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT06380816 Phase 1, Phase 2
Recruiting
Enrollment
167 pts
Location
United Kingdom
Sponsor
Cancer Research UK
NCT07158164 Phase 4
Recruiting
Enrollment
100 pts
Location
United States
Sponsor
Rutgers, The State University ...
NCT06663319 Phase 1
Recruiting
Enrollment
260 pts
Location
United States, South...
Sponsor
Janssen Research & Development...
NCT03303833
Recruiting
Enrollment
1,000 pts
Location
Netherlands
Sponsor
Wageningen University
NCT01915225
Recruiting
Enrollment
1,800 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT07299071
Recruiting
Enrollment
592 pts
Location
France
Sponsor
University Hospital, Bordeaux
Related Conditions
carcinoma non small cell lung (2) cholangiocarcinoma (2) bile duct cancer (2) carcinoma pancreatic ductal (1) metastatic colorectal cancer mcrc (1) intrahepatic cholangiocarcinoma icc (1) intrahepatic bile duct cancer (1) colorectal cancer (1) bile duct neoplasms (1) adrenocortical carcinoma acc (1) adrenal cortical carcinoma (1) adrenal gland cancer (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology